The launch follows a Delhi High Court nod allowing sales of the cancer drug biosimilar ahead of patent expiry in May 2026.
Zydus launches cancer biosimilar nivolumab at steep discount
📅 Published: January 22, 2026 |
📂 Category: Uncategorized
